Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Catalyst Pharmaceutical Partners Inc buy Truist Financial Co.

Start price
€16.76
15:15 / 50%
Target price
€27.48
09.08.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 09.08.25. The prediction end date can be changed by Truist_Financial_Co_ at any time.
Performance without dividends (%)
Name 1w
Catalyst Pharmaceutical Partners Inc -
iShares Core DAX® -1.941%
iShares Nasdaq 100 -3.642%
iShares Nikkei 225® -2.728%
iShares S&P 500 -3.440%

Comments by Truist_Financial_Co_ for this prediction

In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Prediction Buy
Perf. (%) -
Target price 27.477
Change
Ends at 09.08.25

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) had its price target raised by analysts at Truist Financial Co. from $25.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for CPRX provided by MarketBeat